Evotec’s Partner Roche Provides Initial Update From Phase IIb Trial in Alzheimer’s Disease
June 30, 2015 15:27 ET
|
Evotec AG
HAMBURG, Germany, June 30, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) was updated today by its partner Roche (SIX:RO) (SIX:ROG) (OTCQX:RHHBY) on the initial...
Resolutions of the Annual General Meeting of Evotec AG
June 09, 2015 11:21 ET
|
Evotec AG
Approval of All Agenda Items With the Required MajorityActions of Management Board and Supervisory Board ApprovedNew Supervisory Board Member Elected: Dr. Elaine SullivanContingent Capital for the...
Evotec to Present at the Jefferies 2015 Global Healthcare Conference (New York)
May 27, 2015 08:22 ET
|
Evotec AG
HAMBURG, Germany, May 27, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) announced today that its CEO, Dr. Werner Lanthaler will present at the Jefferies 2015 Global...
Evotec AG Reports Results of First Quarter 2015
May 12, 2015 01:52 ET
|
Evotec AG
VERY STRONG START TO 2015: 22% GROWTH OF GROUP REVENUES, MAINLY DRIVEN BY EVT EXECUTE
MAJOR MULTI-COMPONENT STRATEGIC ALLIANCE WITH SANOFI CLOSED
FULL-YEAR REVENUE GUIDANCE...
Facio Partners With Evotec and Initiates FSHD Drug Discovery Programme
April 29, 2015 01:40 ET
|
Evotec AG
HAMBURG, Germany, April 29, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Facio Therapies ("Facio") announced today that they have entered into an agreement aimed...
Evotec FY 2014: Strong Performance in EVT Execute and Acceleration of EVT Innovate
March 24, 2015 02:45 ET
|
Evotec AG
HAMBURG, Germany, March 24, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Prime Standard Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced its financial results for the fiscal year...
Evotec and Sanofi Sign Definitive Agreement for Major Multi-Component Strategic Alliance
March 19, 2015 20:11 ET
|
Evotec AG
Total deal value of € 250 m, including more than € 40 m upfront cash payment
Long-term discovery service collaboration with Sanofi
Major pipeline-building...
Evotec AG: Fiscal Year 2014 Results Presentation on 24 March 2015
March 17, 2015 06:38 ET
|
Evotec AG
HAMBURG, Germany, March 17, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for 2014 on Tuesday, 24 March 2015.
The...
Second Genome and Evotec to Collaborate in Microbiome Discovery and Development
March 13, 2015 02:46 ET
|
Evotec AG
HAMBURG, Germany, March 13, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Second Genome, Inc. today announced a collaboration in small molecule-based discovery...
Evotec and C4XD Enter Collaboration to Identify Pre-Clinical Development Candidates for Stress-Related Addictive Disorder Programme
January 19, 2015 01:38 ET
|
Evotec AG
Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure across chemistry & biology
Efforts will combine the use of C4XD's proprietary NMR technology...